The SNP rs402710 in 5p15.33 Is Associated with Lung Cancer Risk: A Replication Study in Chinese Population and a Meta-Analysis

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Lu, Xuzai ^a,b   Ke, Juntao ^a   Luo, Xia ^a   Zhu, Yaowu ^a   Zou, Li ^a   Li, Huijun ^a   Zhu, Beibei ^a   Xiong, Zhigang ^a   Chen, Wei ^a   Deng, Lingyan ^a   Lou, Jiao ^a   Wang, Xianxiu ^a   Zhang, Yu ^a   Wang, Zhenling ^a   Miao, Xiaoping ^a   Cheng, Liming ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Maternal and Child Health Hospital of Guangdong Province   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHINESE; CONFIDENCE INTERVAL; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LUNG NON SMALL CELL CANCER; POPULATION RESEARCH; REPLICATION STUDY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SYSTEMATIC REVIEW; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CHROMOSOME 5; GENETIC PREDISPOSITION; GENETICS; LUNG NEOPLASMS; META ANALYSIS; RISK;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; CHROMOSOMES, HUMAN, PAIR 5; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; LUNG NEOPLASMS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING;

EID: 84886064226     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076252     Document Type: Article

References (44)

1. Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer 127: 2893-2917.
2. Brennan P, Hainaut P, Boffetta P, (2011) Genetics of lung-cancer susceptibility. Lancet Oncology 12: 399-408.
3. Liu L, Wu J, Wu C, Wang Y, Zhong R, et al. (2011) A functional polymorphism (-1607 1G→2G) in the matrix metalloproteinase-1 promoter is associated with development and progression of lung cancer. Cancer 117: 5172-5181.
4. Chung CC, Magalhaes WCS, Gonzalez-Bosquet J, Chanock SJ, (2009) Genome-wide association studies in cancer-current and future directions. Carcinogenesis 31: 111-120.
5. Wu C, Miao X, Huang L, Che X, Jiang G, et al. (2012) Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations. Nat Genet 44: 62-66.
6. Garcia-Barcelo MM, Yeung MY, Miao XP, Tang CS, Cheng G, et al. (2010) Genome-wide association study identifies a susceptibility locus for biliary atresia on 10q24.2. Hum Mol Genet 19: 2917-2925.
7. Wang L, Wu XP, Zhang W, Zhu DH, Wang Y, et al. (2011) Evaluation of genetic susceptibility loci for chronic hepatitis B in Chinese: two independent case-control studies. PLoS One 6: e17608.
8. Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, et al. (2008) A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452: 633-637.
9. Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, et al. (2008) Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nature Genetics 40: 616-622.
10. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, et al. (2008) A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452: 638-642.
11. Wang Y, Broderick P, Webb E, Wu X, Vijayakrishnan J, et al. (2008) Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nature Genetics 40: 1407-1409.
12. McKay JD, Hung RJ, Gaborieau V, Boffetta P, Chabrier A, et al. (2008) Lung cancer susceptibility locus at 5p15.33. Nature Genetics 40: 1404-1406.
13. Yamamoto K, Okamoto A, Isonishi S, Ochiai K, Ohtake Y, (2001) A novel gene,CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis. Biochem Biophys Res Commun 280: 1148-1154.
14. Jaworowska E, Trubicka J, Lener MR, Masojc B, Zlowocka-Perlowska E, et al. (2011) Smoking related cancers and loci at chromosomes 15q25, 5p15, 6p22.1 and 6p21.33 in the Polish population. PLoS One 6: e25057.
15. Pande M, Spitz MR, Wu XF, Gorlov IP, Chen WV, et al. (2011) Novel genetic variants in the chromosome 5p15.33 region associate with lung cancer risk. Carcinogenesis 32: 1493-1499.
16. Truong T, Hung RJ, Amos CI, Wu X, Bickeboller H, et al. (2010) Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst 102: 959-971.
17. Hsiung CA, Lan Q, Hong YC, Chen CJ, Hosgood HD, et al. (2010) The 5p15.33 Locus Is Associated with Risk of Lung Adenocarcinoma in Never-Smoking Females in Asia. Plos Genetics 6.
18. Ito H, McKay JD, Hosono S, Hida T, Yatabe Y, et al. (2012) Association between a Genome-Wide Association Study-Identified Locus and the Risk of Lung Cancer in Japanese Population. Journal of Thoracic Oncology 7: 790-798.
19. Yoon KA, Park JH, Han J, Park S, Lee GK, et al. (2010) A genome-wide association study reveals susceptibility variants for non-small cell lung cancer in the Korean population. Hum Mol Genet 19: 4948-4954.
20. Chen XF, Cai S, Chen QG, Ni ZH, Tang JH, et al. (2012) Multiple variants of TERT and CLPTM1L constitute risk factors for lung adenocarcinoma. Genet Mol Res 11: 370-378.
21. Jin G, Xu L, Shu Y, Tian T, Liang J, et al. (2009) Common genetic variants on 5p15.33 contribute to risk of lung adenocarcinoma in a Chinese population. Carcinogenesis 30: 987-990.
22. Yang P, Li Y, Jiang R, Cunningham JM, Zhang F, et al. (2010) A rigorous and comprehensive validation: common genetic variations and lung cancer. Cancer Epidemiol Biomarkers Prev 19: 240-244.
23. Zhong H, Prentice RL, (2009) Correcting "winner's curse" in odds ratios from genomewide association findings for major complex human diseases. Genetic Epidemiology: n/a-n/a.
24. Pabalan NA, (2010) Meta-Analysis in Cancer Genetics. Asian Pacific Journal of Cancer Prevention 11: 33-38.
25. Knobloch K, Yoon U, Vogt PM, (2011) Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias. Journal of Cranio-Maxillofacial Surgery 39: 91-92.
26. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. (2000) Meta-analysis of observational studies in epidemiology- A proposal for reporting. Jama-Journal of the American Medical Association 283: 2008-2012.
27. Higgins JPT, Thompson SG, (2002) Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 21: 1539-1558.
28. Higgins JP TS, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
29. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 22: 719-748.
30. Mullen B, Muellerleile P, Bryant B, (2001) Cumulative meta-analysis: A consideration of indicators of sufficiency and stability. Personality and Social Psychology Bulletin 27: 1450-1462.
31. Thakkinstian A, McElduff P, D'Este C, Duffy D, Attia J, (2005) A method for meta-analysis of molecular association studies. Statistics in Medicine 24: 1291-1306.
32. Begg CB, Mazumdar M, (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
33. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
34. Duval S, Tweedie R, (2000) Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56: 455-463.
35. Broderick P, Wang Y, Vijayakrishnan J, Matakidou A, Spitz MR, et al. (2009) Deciphering the Impact of Common Genetic Variation on Lung Cancer Risk: A Genome-Wide Association Study. Cancer Research 69: 6633-6641.
36. Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, et al. (2009) A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma. The American Journal of Human Genetics 85: 679-691.
37. Xun WW, Brennan P, Tjonneland A, Vogel U, Overvad K, et al. (2011) Single-nucleotide polymorphisms (5p15.33, 15q25.1, 6p22.1, 6q27 and 7p15.3) and lung cancer survival in the European Prospective Investigation into Cancer and Nutrition (EPIC). Mutagenesis 26: 657-666.
38. Zienolddiny S, Skaug V, Landvik NE, Ryberg D, Phillips DH, et al. (2009) The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung. Carcinogenesis 30: 1368-1371.
39. Young RP, Hopkins RJ, Whittington CF, Hay BA, Epton MJ, et al. (2011) Individual and cumulative effects of GWAS susceptibility loci in lung cancer: associations after sub-phenotyping for COPD. PLoS One 6: e16476.
40. Bae EY, Lee SY, Kang BK, Lee EJ, Choi YY, et al. (2012) Replication of results of genome-wide association studies on lung cancer susceptibility loci in a Korean population. Respirology 17: 699-706.
41. Kang JU, Koo SH, Kwon KC, Park JW, Kim JM, (2008) Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer. Cancer Genetics and Cytogenetics 182: 1-11.
42. Yamamoto K, Okamoto A, Isonishi S, Ochiai K, Ohtake Y, (2001) A Novel Gene, CRR9, Which Was Up-Regulated in CDDP-Resistant Ovarian Tumor Cell Line, Was Associated with Apoptosis. Biochemical and Biophysical Research Communications 280: 1148-1154.
43. James MA, Wen W, Wang Y, Byers LA, Heymach JV, et al. (2012) Functional Characterization of CLPTM1L as a Lung Cancer Risk Candidate Gene in the 5p15.33 Locus. PLoS ONE 7: e36116.
44. Mocellin S, Verdi D, Pooley KA, Landi MT, Egan KM, et al. (2012) Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis. J Natl Cancer Inst 104: 840-854.